Page last updated: 2024-10-29

indomethacin and Hashimoto Disease

indomethacin has been researched along with Hashimoto Disease in 1 studies

Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.

Hashimoto Disease: Chronic autoimmune thyroiditis, characterized by the presence of high serum thyroid AUTOANTIBODIES; GOITER; and HYPOTHYROIDISM.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taddei, S1
Caraccio, N1
Virdis, A1
Dardano, A1
Versari, D1
Ghiadoni, L1
Ferrannini, E1
Salvetti, A1
Monzani, F1

Trials

1 trial available for indomethacin and Hashimoto Disease

ArticleYear
Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis.
    The Journal of clinical endocrinology and metabolism, 2006, Volume: 91, Issue:12

    Topics: Acetylcholine; Adult; Algorithms; Ascorbic Acid; Celecoxib; Cyclooxygenase 2; Endothelium, Vascular;

2006